文献速递白内障与屈光手术青光眼眼底病与葡萄膜炎

加速生物学衰老与白内障易感性的关联:跨队列分析证据

Linking accelerated biological ageing to cataract susceptibility: evidence from cross-cohort analysis.
PubMed 文献 · Br J Ophthalmol · 2026-05-12

结果显示加速生物学衰老与白内障风险升高正相关,视网膜年龄加速效应量最大(HR 1.54)。

要点

  • 加速生物学衰老与白内障风险升高正相关,视网膜年龄加速效应量最大。
  • 仅英国人群中,青光眼风险与KDMAge加速关联更强(HR 1.06)。
  • 仅英国人群中,AMD与PhenoAge加速关联更明显(HR 1.08)。

核心结论

  • 加速生物学衰老可能是白内障评估和干预的潜在靶点。

主要发现

  • 横断面和纵向分析中,加速生物学衰老均与白内障风险增加正相关(所有p<0.05)。
  • 纵向队列中,RetiAge加速对白内障的效应量估计(HR 1.54,95%CI 1.38-1.73)大于PhenoAge加速(HR 1.05,95%CI 1.03-1.08)和KDMAge加速(HR 1.06,95%CI 1.04-1.08)。
  • 仅在英国人群中,青光眼风险与KDMAge加速关联更强(HR 1.06,95%CI 1.01-1.11),AMD与PhenoAge加速关联更明显(HR 1.08,95%CI 1.02-1.14)。

临床怎么用

  • 对40岁及以上人群,可考虑将加速生物学衰老(尤其是视网膜年龄加速)作为白内障风险评估的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The cross-sectional and longitudinal associations between accelerated biological ageing and the risk of cataract and other blinding eye diseases (including glaucoma and age-related macular degeneration (AMD)) remain unclear. METHODS: We included participants aged 40 and above with biological ages, including phenotypic age (PhenoAge), Klemera-Doubal method (KDMAge) and retinal age (RetiAge), from the US National Health and Nutrition Examination Survey (NHANES) and UK Biobank. The cross-sectional analyses were conducted to identify associations of PhenoAge or KDMAge acceleration with cataract and other blinding eye diseases using logistic regression. In a prospective UK cohort, we explored the relationships between the acceleration of PhenoAge, KDMAge or RetiAge and cataract and other blinding eye diseases using the Cox proportional hazards model. RESULTS: This study consisted of 5433 participants from the US NHANES and 269 615 participants from the UK Biobank. In both cross-sectional and longitudinal analyses, accelerated biological ageing was positively associated with an increased risk of cataract (all p<0.05). In a longitudinal cohort, RetiAge acceleration demonstrated the larger effect size estimates (HR 1.54 (95% CI 1.38 to 1.73)) compared with PhenoAge acceleration (HR 1.05 (95% CI 1.03 to 1.08)) and KDMAge acceleration (HR 1.06 (95% CI 1.04 to 1.08)). Only in the UK population, risks of glaucoma showed stronger links with KDMAge acceleration (HR 1.06 (95% CI 1.01 to 1.11)), while AMD showed more pronounced associations with PhenoAge acceleration (HR 1.08 (95% CI 1.02 to 1.14)). CONCLUSIONS: Accelerated biological ageing might represent a potential target of assessment and intervention for cataract.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chi K, He Y, Zuo X, et al. Linking accelerated biological ageing to cataract susceptibility: evidence from cross-cohort analysis. Br J Ophthalmol. 2026. PMID: 42097863. doi:10.1136/bjo-2025-329061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。